Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma
- 27 December 2014
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 36 (5) , 3601-3610
Abstract
Prognosis in patients with lung cancer is poor. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) are proteins involved in the invasion and metastases of cancer. The objective of this study is to determine if there is a relationship between tumor expression of NGAL and MMP-9 in lung adenocarcinoma patients with prognosis and overall survival. Retrospective analysis was made of patients with lung adenocarcinoma treated at Medica Sur Hospital between 2005 and 2013. Tumor tissue was analyzed for NGAL and MMP-9 expression by immunohistochemistry. We identified 41 patients. Mean overexpression in tumoral tissue of NGAL was 70 % and 30 % for MMP-9. Univariate analysis revealed that prognostic factors associated with overall survival (OS) were NGAL expression and stage at diagnosis. Median OS for NGAL expression P P = 0.002). No differences in OS were found for expression of MMP-9. Multivariate analysis revealed significance for OS in NGAL expression (HR 5.01 [95 % CI; 1.68–14.93] P = 0.004) and stage at diagnosis (HR 2.05 [95 % CI 1.30–3.22] P = 0.002). Tumoral tissue expression of NGAL ≥70 % confers a worse prognosis compared to those who did not. NGAL is an independent prognostic factor of stage at diagnosis.Keywords
This publication has 47 references indexed in Scilit:
- Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumorsOncology Letters, 2013
- Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic CancerPLOS ONE, 2013
- Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast CancerPLOS ONE, 2012
- Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer diseaseBMC Cancer, 2009
- Clinical significance of Neutrophil gelatinase-associated lipocalin(NGAL) expression in primary rectal cancerBMC Cancer, 2009
- NGAL decreases E-cadherin-mediated cell–cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cellsLaboratory Investigation, 2009
- The Kazal motifs of RECK protein inhibit MMP‐9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivoJournal of Cellular and Molecular Medicine, 2008
- Neutrophil Gelatinase–Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic CancerCancer Research, 2008
- Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancerBreast Cancer Research and Treatment, 2007
- Lipocalins and cancerBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000